Abstract
In 1976, Morgan and colleagues reported that conditioned media from mitogen-stimulated mononuclear cells contained a factor which maintained the exponential proliferative growth of human leukemic blood or bone marrow cells (1); the proliferative cells were identified as normal T lymphocytes (2). Isolation, characterization, and subsequent purification of this factor in the conditioned medium lead to the identification of a T cell growth factor (TCGF) now known as IL-2 (3), a glycoprotein of 15.5 kD with a slightly basic isoelectric point (4). Shortly thereafter, Taniguchi et al. (5) isolated a cDNA clone for IL-2. Although IL-2 was initially described as the ultimate mitogenic signal for both antigenically and polyclonally activated T cells, aiding in their cell cycle transition from G1 to S phase (6), subsequent studies showed that IL-2 stimulates NK and LAK cell activity (7, 8), induces B cell differentiation and proliferation (9), and activates macrophage cytotoxicity (10). IL-2 also participates in induction of T cell synthesis of cytokines, such as IFN-γ (11) and B cell growth factor-1, or IL-4 (12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. A. Morgan, F. W. Ruscett, and R. C. Gallo, Selective in vitro growth of T lymphocytes from normal human bone marrows, Science 193:1007 (1976).
F. W. Ruscett, D. A. Morgan, and R. C. Gallo, Functional and morphologic characterization of human T cells continuously grown in vitro, J. Immunol. 119:131 (1977).
K. A. Smith, Interleukin-2: Inception, Impact and Implications, Science. 240:1169 (1988).
R. J. Robb and K. A. Smith, heterogeneity of human T cell growth factor due to glycosylation, Mol. Immunol. 18:1087 (1981).
T. Taniguchi, H. Matsui., T. Fujita, C. Takaoka, N. Kashima, R. Yoshimoto, and J. Hamuor, Structure and expression of a cloned cDNA for human interleukin-2, Nature (London) 302:305.
B. M. Stadler, S. F. Dougherty, J. J. Farrar, and J. J. Oppenheim, Relationship of cell cycle recovery of IL-2 activity from human mononuclear cells, human and mouse T cell lines, J. Immunol. 127:1936 (1981).
W. Domzig, B. M. Stadler, and R. B. Herberman, Interleukin-2 dependence of human natural killer (NK) cell activity, J. Immunol. 130:1970 (1983).
C. S. Henney, K. Kuribayashi, D. E. Kern, and S. Gillis, Interleukin-2 augments natural killer cell activity, Nature (London) 291:335 (1981).
R. J. Robb, Interleukin-2: the molecule and its function, Immunol. Today 5:203. (1984).
M. Malkovsky, B. Loveland, M. North, G. L. Asherson, L. Gao, P. Ward, and W. Fiers, Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes, Nature 325:262 (1987)
J. J. Farrar, W. R. Benjamin, M. L. Hilfiker, M. Howard, W. L. Farrar, and J. Fuller-Farrar, The biochemistry, biology and role of interleukin-2 in the induction of cytotoxic T cell and antibody-forming B cell responses, Immunol. Rev. 63:129 (1982).
M. Howard, L. Matis, T. R. Malek, E. Shevach, W. Keuk, D. Cohen, K. Nakanishi, and W. E. Paul, Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-1, J. Exp. Med. 158:2024 (1983).
K. Teshigawara, H-M Wang, K. Kato, and K. A. Smith, Interleukin 2 high-affinity receptor expression requires two distinct binding proteins, J. Exp. Med. 165:223 (1987).
T. Uchiyama, S. Border, and T. A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells, J. Immunol. 126:1293 (1981).
W. J. Leonard, J. M. Depper, T. Uchiyama, K. A. Smith, T. A. Waldman, and W. C. Green, A monoclonal antibody that appears to recognize the receptor for human T cell growth factor, Nature 300:267 (1982).
J. H. Kehrl, M. Dukovich, G. Whalen, P. Katz, A. S. Fauci, and W. C. Greene, Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells, J. Clin. Invest. 81:200 (1988).
R. J. Robb and W. C. Greene, Internalization of IL-2 is mediated by the beta chain of the high affinity IL-2 receptor, J. Exp. Med. 165:1201 (1987).
L. T. Bich-Thuy, M. Dukovich, N. J. Peffer, A. S. Fauci, J. H. Kehrl, and W. C. Greene, Direct activation of human resting T cells by IL-2: the role of an IL-2 receptor distinct from the tac protein, J. Immunol. 139:1550 (1987).
J. L. Lowenthal and W. C. Greene, Contrasting IL-2 binding properties of alpha (tac) and beta (p70) protein subunits of the human high affinity IL-2 receptor complex, J. Exp. Med. 166:1156 (1987).
T. A. Waldman, C. K. Goldman, R. J. Robb, J. M. Depper, W. J. Leonard, S. O. Sharrow, K. F. Bongiovanni, S. J. Korsmeyer, and W. C. Greene, Expression of interleukin 2 receptors on activated human B cells, J. Exp. Med. 160:1450 (1984).
A. W. Boyd, D. C. Fisher, D. A. Fox, S. F. Schlossman, and L. M. Nadler, Structural and functional characterization of IL 2 receptors on activated human B cells, J. Immunol. 134:2387 (1985).
R. Mittler, P. Rao, G. Olini, E. Westberg, W. Newman, M. Hoffman, and G. Goldstein, Activated human B cells display a functional IL 2 receptor, J. Immunol. 134:2393 (1985).
W. Holter, R. Grunow, H. Stockinger, and W. Knapp, Recombinant interferon-γ induces IL-2 receptors on human peripheral blood monocytes, J. Immunol. 136:2171 (1986).
W. Holter, C. K. Goldman, L. Casabo, D. L. Nelson, W. C. Greene, and T. A. Waldmann, Expression of functional IL 2 receptors by lipopolysaccharide and interferon-γ stimulated human monocytes, J. Immunol. 138:2917 (1987).
W. W. Hancock, W. A. Muller, and R. S. Cotran, Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines, J. Immunol. 138:185 (1987).
G. Steiner, E. Tschachler, M. Tani, T. R. Malek, E. M. Shevach, W. Holter, W. Knapp, K. Wolff, and G. Stingl, Interleukin 2 receptors on cultured murine epidermal Langerhans cells, J. Immunol. 137:155 (1986).
S. M. Wahl, N. McCartney-Francis, D. A. Hunt, P. D. Smith, L. M. Wahl, and I. M. Katona, Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity, J. Immunol. 139:1342 (1987).
W. J. Leonard, M. Kronke, N. J. Peffer, J. M. Depper, and W. C. Greene, Interleukin 2 receptor gene expression in normal human T lymphocytes, Proc. Natl. Acad. Sci. USA 82:6281 (1985).
A. Rambaldi, D. C. Young, F. Herrmann, S. A. Cannistra, and J. D. Griffin, Interferon-γ induces expression of the interleukin 2 receptor gene in human monocytes, Eur. J. Immunol. 17:153. (1987).
I. Espinoza-Delgado, J. R. Ortaldo, R. Winkler-Pickett, K. Sugamura, L. Varesio, and D. L. Longo, Expression and role of p75 interleukin 2 receptor on human monocytes, J. Exp. Med. 171:1821 (1990).
G. W. Cox, B. J. Mathieson, S. L. Giardina, and L. Varesio, Characterization of IL-2 receptor expression and function on murine macrophages, J. Immunol. 145:1719 (1990).
P. D. Smith, D. B. Keister, and C. O. Elson, human host response to Giardia lamblia. I. Spontaneous killing by mononuclear leukocytes in vitro, J. Immunol. 128:1372 (1983).
R. M. Strieter, D. G. Remick, J. P. Lynch, R. N. Spengler, and S. L. Kunkel, Interleukin-2-induced tumor necrosis factor-alpha (TNF-α) gene expression in human alveolar macrophages and blood monocyte, Am. Rev. Resp. Dis. 139:335 (1989).
E. J. Kovacs, B. Brock, L. Varesio, and H. A. Young, IL-2 induction of IL-1 mRNA expression in monocytes: regulation by agents that block second messenger pathways, J. Immunol. 143:3532 (1989).
F. Herrmann, S. A. Cannistra, A. Lindemann, D. Blohm, A. Rambaldi, R. H. Mertelsmann, and J. D. Griffin, Functional consequences of monocyte IL-2 receptor expression: induction of IL-1β secretion by IFN-γ and IL-2, J. Immunol. 142:139 (1989).
C. A. Nacy, B. J. Nelson, S. J. Green, and A. I. Meierovics, Cytokine networks and regulation of macrophage antimicrobial activities, in: “Cellular and Cytokine Networks in Tissue Immunity,” M. S. Meltzer and A. Montovani, eds., Wiley-Liss, Inc., New York, (1991).
J. S. Economou, W. H. McBride, R. Essner, K. Rhoades, S. Golub, E. C. Holmes, and D. L. Morton, Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo, Immunology 67:514 (1989).
S. Narumi, J. H. Finke, and T. A. Hamilton, Interferon γ and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages, J. Biol. Chem. 265:7036 (1990).
M. G. Pappas, C. A. Nacy, Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG, Cell. Immunol. 80:217 (1983).
C. A. Nacy, M.S. Meltzer, E. J. Leonard, and D. J. Wyler, Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages, J. Immunol. 127:2381 (1981).
H. C. Miller and D. W. Twohy, Cellular immunity to Leishmania donovani in macrophages in cultures, J. Parasitol. 55:200 (1969).
C. A. Nacy and M. S. Meltzer, Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing Rickettsia tsutsugamushi. J. Immunol. 123:2544 (1979).
S. B. Salvin and S.-L. Cheng, Lymphoid cells in delayed-type hypersensitivity II. in vitro phagocytosis and cellular immunity, Infect. Immun. 3:548 (1971).
R. Hoff, Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross immunity on challenge in vivo, J. Exp. Med. 142:299 (1975).
M. A. Horwitz and S. C. Silverstein, Activated human monocytes inhibit the intracellular multiplication of Legionnaires’ disease bacteria, J. Exp. Med. 154:1618 (1981).
C. A. Nacy and M. S. Meltzert Macrophages in resistance to rickettsial infection: strains of mice susceptible to the lethal effects of Richettsia akari infection show defective microbicidal activity in vitro, Infect. Immun. 126:204 (1981).
M. Belosevic, D. S. Finbloom, M. S. Meltzer and C. A. Nacy, IL-2: A cofactor for induction of activated macrophage resistance to infection, J. Immunol. 145:831 (1990).
C. A. Nacy, C. N. Oster, S. L. James, and M. S. Meltzer, Activation of macrophages for destruction of intracellular and extracellular parasites, Contemp. Top. Immunobiol. 13:147 (1984).
C. A. Nacy, E. J. Leonard, and M. S. Meltzer, Macrophages in resistance to rickettsial infections: characterization of the lymphokines that induce rickettsiacidal activity in macrophages, J. Immunol. 126:204 (1981).
M. Belosevic, C. E. Davis, M. S. Meltzer, and C. A. Nacy, Regulation of macrophage antimicrobial activities: identification of lymphokines that cooperate with IFN-γ for induction of resistance to infection, J. Immunol. 141:890 (1988).
C. E. Davis, M. Belosevic, M. S. Meltzer, and C. A. Nacy, Regulation of activated macrophage antimicrobial activities: cooperation of lymphokines for induction of resistance to infection, J. Immunol. 141:627 (1988).
P. Ralph, C. A. Nacy, M. S. Meltzer, N. Williams, I. Nakionz, and E. J. Leonard, Colony stimulating factors and regulation of macrophage tumoricidal and microbicidal activities, Cell Immun. 76:10 (1983).
C. A. Nacy, A. I. Meierovics, M. Belosevic, and S. J. Green, TNF-α: central regulatory cytokine in the induction of macrophage antimicrobial activities, Pathobiol. 59:182 (1991).
T. A. Hamilton, D. A. Becton, S. D. Somers, and D. O. Adams, Interferon γ modulates protein kinase C activity in murine peritoneal macrophages, J. Biol. Chem. 260:1378 (1985).
D. A. Becton, D. O. Adams, and T. A. Hamilton, Characterization of protein kinase C activity in interferon γ-treated murine peritoneal macrophages, J. Cell. Physiol. 125:485 (1986).
M. Belosevic and C. A. Nacy, Interleukin-2, Anti-interleukin-2 receptor antibody, and activation of macrophages, Cell. Immunol. 128:635 (1990).
G. Ortega, R. J. Robb, E. M. Shevach, and T. R. Malek, The murine IL-2 receptor I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells, J. Immunol. 133:1970 (1984).
T. R. Malek, R. J. Robb, and E. M. Shevach, Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin-2 receptor ligand complex, Proc. Nat. Acad. Sci. USA 80:5694 (1983).
C. N. Oster and C. A. Nacy, Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce microbicidal activities against Leishmania tropica amastigotes, J. Immunol. 132:1492 (1984).
R. M. Crawford, A. H. Fortier, M. Belosevic, and C. A. Nacy, Macrophage Killing Mechanisms, in: “Immunopharmacology,” T. J. Rogers and S. C. Gelman, eds., Telford Press, NJ (1990).
A. H. Fortier, S. J. Green, T. Polsinelli, and C. A. Nacy, Murine peritoneal macrophage interactions with Francisella tularensis live vaccine strain: characterization of growth and interferon-γ induced inhibition of growth in vitro (in preparation).
L. P. Ruco and M. S. Meltzer, Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation, J. Immunol. 120:1054 (1978).
D. L. Hoover and C. A. Nacy, Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents, J. Immunol. 132:1487 (1984).
S. J. Green, M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy, Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism, J. Immunol. 144:278 (1990).
L. P. Ruco and M. S. Meltzer, Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reaction, J. Immunol. 121:2035 (1978).
S. J. Green, R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy, Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α, J. Immunol. 145:4290 (1990).
B. J. Nelson, P. Ralph, S. J. Green, and C. A. Nacy, Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1, J. Immunol. 146:1849 (1991).
C. A. Nacy, Macrophage activation to kill Leishmania tropica: characterization of a T cell derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes, J. Immunol. 133:448 (1984).
M. S. Meltzer, W. R. Benjamin, and J. J. Farrar, Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4 fluids, a continuous T cell line, J. Immunol. 129:2802 (1982).
M. L. Hilfiker, R. N. Moore, and J. J. Farrar, Biological properties of chromatographically separated murine thymoma derived interleukin 2 and colony-stimulating factor. J. Immunol. 127:1983 (1981).
M. Howard, J. Farrar, M. Hilfiker, B. Johnson, and W. Paul, Identification of a T-cell derived B-cell growth factor distinct from interleukin 2, J. Exp. Med. 155:914 (1982).
J. J. Farrar, J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler, and W. L. Farrar, Thymoma production of T cell growth factor (interleukin 2), J. Immunol. 125:2555 (1982).
B. J. Nelson, J. Rossio, and C. A. Nacy, The EL-4 suppressor factor that blocks development of macrophage intracellular killing activities works through the induction of TGF-β-1, (in preparation).
N. E. Reiner and J. H. Finke, Interleukin 2 deficiency in murine leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin, J. Immunol. 131:1487 (1983).
E. Cillari, F. Y. Liew, and R. Lelchuk, Suppression of interleukin 2 production by macrophages in genetically susceptible mice infected with Leishmania major, Infect. Immun. 54:386 (1983).
A. Harell-Bellani, A. Joskowitz, D. Fradelizi, and H. Elsen, Modification of T cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 80:3466 (1983).
R. Lelchuk, R. Rose, and J. H. L. Playfair, Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection, Cell. Immunol. 84:253 (1983).
V. Coolizi, In vivo and in vitro administration of interleukin 2-containing preparation reverses T cell responsiveness in Mycobacterium bovis BCG-infected mice. Infect. Immun. 45:25 (1984).
S. R. Watson, S. K. Schmitt, D. E. Hendricks, and W. E. Bullock, Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2, J. Immunol. 135:3487 (1985).
G. Kaplan, D. E. Weinstein, R. M. Steinman, W. R. Lewis, U. Elvers, M. E. Patattoyo, and Z. A. Cohn, An analysis of in vitro T cell responsiveness in lepromatous leprosy, J. Exp. Med. 162:917 (1985).
A. Harengowoin, T. Godal, A. S. Mustafa, A. Belehn, and T. Yemaneberhan, T cell conditioned media reverse T cell unresponsiveness in lepromatous leprosy, Nature 303:342 (1985).
S. D. Sharma, J. M. Hofflin, and J. S. Remington, In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J. Immunol. 135:4160 (1985).
M. A. Cheever, P. D. Greenberg, A. Fefer, and S. Gillis, Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2, J. Exp. Med. 155:968 (1983).
M. Malkovsky, P. D. Medawar, F. R. S. Hunt, L. Palmer, and C. Dore, A diet enriched in vitamin A acetate or in vivo administration of interleukin 2 can counteract a tolerigenic stimulus, Proc. R. Soc. Lond. (Biol.) 220:439 (1984).
H. Wagner, C. Hardt, K. Heeg, M. Rolinghoff, and K. Pfizenmaier, T cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice, Nature 284:278 (1980).
S. N. Hafeneider, P. J. Conlon, C. S. Henney, and S. Gillis, In vivo interleukin 2 administration augments the generation of alloreactive T lymphocytes and resident natural killer cells, J. Immunol. 130:222 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nelson, B.J., Belosevic, M., Green, S.J., Turpin, J., Nacy, C.A. (1992). Interleukin-2 and the Regulation of Activated Macrophage Cytotoxic Activities. In: Friedman, H., Klein, T.W., Yamaguchi, H. (eds) Microbial Infections. Advances in Experimental Medicine and Biology, vol 319. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3434-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3434-1_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6519-8
Online ISBN: 978-1-4615-3434-1
eBook Packages: Springer Book Archive